Oxford covid-19 vaccine: AstraZeneca must explain spinal ailment to resume trial
A day after pausing its Covid-19 vaccine trials due to a possible serious neurological problem in one patient, AstraZeneca Plc faced numerous questions about what exactly caused the issue and…